Chargement en cours...
Non-conventional fotemustine schedule as second-line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature
Fotemustine (FTM) is a treatment option in recurrent malignant gliomas (MGs) after first-line Stupp treatment. The efficacy and the safety of fractionated FTM schedule proposed by Addeo et al was analysed in the present study in recurrent MGs patients. A retrospective analysis on 40 recurrent MGs pa...
Enregistré dans:
| Publié dans: | Mol Clin Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313958/ https://ncbi.nlm.nih.gov/pubmed/30655978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1746 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|